National Institute of Nursing Research; Notice of Meeting, 67319-67320 [2023-21433]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices
Steering Committee, which are
comprised of a broad coalition of
organizational representatives who are
experts in disease prevention and
women’s health issues. With oversight
by the Advisory Panel, and with input
from the Multidisciplinary Steering
Committee, WPSI examines the
evidence to develop new (and update
existing) recommendations for women’s
preventive services. WPSI’s
Dissemination and Implementation
Steering Committee takes HRSAapproved recommendations and
disseminates them through the
development of implementation tools
and resources for both patients and
practitioners.
WPSI bases its recommended updates
to the Guidelines on review and
synthesis of existing clinical guidelines
and new scientific evidence, following
the National Academy of Medicine
standards for establishing foundations
for and rating strengths of
recommendations, articulation of
recommendations, and external reviews.
Additionally, HRSA requires that WPSI
incorporate processes to assure
opportunity for public comment,
including participation by patients and
consumers, in the development of its
recommendations to the updated
Guidelines.
removal, if accepted by HRSA, will not
substantively change the existing
guideline. Second, the final sentence of
the clinical recommendation
recommends changing the word
‘‘referring’’ to ‘‘facilitating’’ to reflect
that clinicians in practice, after
screening for urinary incontinence, may
decide to treat or manage urinary
incontinence as part of standard
primary care services or refer to
specialists if specialist care is needed.
Lastly, WPSI recommended minor edits
to the language of the Guideline for the
purposes of clarity. These minor edits
have no substantive effect on the
requirement for coverage without costsharing.
Members of the public can view the
complete updated draft
recommendation, which includes the
implementation considerations and
research recommendations, by accessing
the initiative’s web page at https://
www.womenspreventivehealth.org/.
Extramural Research, National Eye Institute,
National Institutes of Health, 6700 B
Rockledge Dr., Rockville, MD 20892, 301–
451–2020, hoshawb@mail.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel; Pathways to
Independence (K99) Applications.
Date: November 6, 2023.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Eye Institute, 6700B
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Ashley Fortress, Ph.D.,
Designated Federal Official, Division of
Extramural Activities, National Eye Institute,
National Institutes of Health, 6700 B
Rockledge Dr., Bethesda, MD 20817, (301)
451–2020, ashley.fortress@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.867, Vision Research,
National Institutes of Health, HHS)
Carole Johnson,
Administrator.
[FR Doc. 2023–21490 Filed 9–28–23; 8:45 am]
Dated: September 25, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
[FR Doc. 2023–21514 Filed 9–28–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The Existing Guideline States
National Institutes of Health
National Institute of Nursing Research;
Notice of Meeting
‘‘Screening for Urinary Incontinence
WPSI recommends screening women
for urinary incontinence annually.
Screening should ideally assess whether
women experience urinary incontinence
and whether it impacts their activities
and quality of life. The Women’s
Preventive Services Initiative
recommends referring women for
further evaluation and treatment if
indicated.’’
National Eye Institute; Notice of Closed
Meetings
Draft Updated Clinical
Recommendation for Public Comment
‘‘Screening for Urinary Incontinence
The Women’s Preventive Services
Initiative recommends screening women
for urinary incontinence annually.
Screening should assess whether
women experience urinary incontinence
and whether it impacts their activities
and quality of life. If indicated,
facilitating further evaluation and
treatment is recommended.’’
lotter on DSK11XQN23PROD with NOTICES1
67319
Discussion of Draft Updated Clinical
Recommendation
WPSI recommended several minor
updates to the language of this
Guideline. First, the word ‘‘ideally’’ is
recommended to be removed from the
second sentence for brevity, and its
VerDate Sep<11>2014
21:46 Sep 28, 2023
Jkt 259001
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; Mentored Clinical
Scientist Research Career Development
Award (K08/K23) and Conference Grant
(R13) Applications.
Date: October 26, 2023.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Eye Institute, 6700
Rockledge Drive, Bethesda, MD 20817
(Virtual Meeting).
Contact Person: Brian Hoshaw, Ph.D.,
Designated Federal Official, Division of
PO 00000
Frm 00095
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Nursing Research.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below.
Individuals who plan to attend inperson or view the virtual meeting and
need special assistance or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
can be accessed from the NIH Videocast
at the following link: https://
videocast.nih.gov/
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Nursing Research.
E:\FR\FM\29SEN1.SGM
29SEN1
67320
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Date: January 25, 2024.
Open: 9:00 a.m. to 3:00 p.m.
Agenda: Call to Order and Opening
Remarks, NINR Director’s Report, Concepts,
Council Open Discussion.
Place: National Institutes of Health,
Building 31, C-Wing, Sixth Floor, Rooms
A&B, 31 Center Drive, Bethesda, MD 20892
(Hybrid Meeting).
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, C-Wing, Sixth Floor, Rooms
A&B, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Elizabeth Tarlov, Ph.D.,
RN, Director, Division of Extramural Science
Programs (DESP), National Institute of
Nursing Research, Bethesda, MD 20892, (301)
594–1580, elizabeth.tarlov@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of an organization may
submit a letter of intent, a brief description
of the organization represented and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and
presentations may be limited to five minutes.
Both printed and electronic copies are
requested for the record. In addition, any
interested person may file written comments
with the committee by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninr.nih.gov/aboutninr/nacnr, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: September 25, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21433 Filed 9–28–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
21:46 Sep 28, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, NIHAI75N93023R00003:
Pre-clinical Models of Infectious Diseases—
Task Area C.
Date: November 1–2, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G74,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Hailey Peterson Weerts,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G74,
Rockville, MD 20852, (240) 669–5931,
hailey.weerts@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 25, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21357 Filed 9–28–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Synthetic Nucleic Acid
Platforms for HIV–1 (SNAPH): (R61/R33
Clinical Trial Not Allowed).
Date: November 21, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Barry J. Margulies, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G11, Rockville, MD
20852, (301) 761–7956, barry.margulies@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 25, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–21359 Filed 9–28–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Deafness and
Other Communication Disorders
Advisory Council.
This is a virtual meeting and will be
open to the public as indicated below.
The url link to this meeting is: https://
www.nidcd.nih.gov/about/advisorycouncil/upcoming-meetings. Individuals
who plan to attend and need special
assistance, such as sign language
E:\FR\FM\29SEN1.SGM
29SEN1
]]>Agencies
[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Pages 67319-67320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21433]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Nursing Research.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Individuals who plan to
attend in-person or view the virtual meeting and need special
assistance or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The meeting can
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Nursing
Research.
[[Page 67320]]
Date: January 25, 2024.
Open: 9:00 a.m. to 3:00 p.m.
Agenda: Call to Order and Opening Remarks, NINR Director's
Report, Concepts, Council Open Discussion.
Place: National Institutes of Health, Building 31, C-Wing, Sixth
Floor, Rooms A&B, 31 Center Drive, Bethesda, MD 20892 (Hybrid
Meeting).
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Building 31, C-Wing, Sixth
Floor, Rooms A&B, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Elizabeth Tarlov, Ph.D., RN, Director, Division
of Extramural Science Programs (DESP), National Institute of Nursing
Research, Bethesda, MD 20892, (301) 594-1580,
[email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of an organization may submit a letter of
intent, a brief description of the organization represented and a
short description of the oral presentation. Only one representative
of an organization may be allowed to present oral comments and
presentations may be limited to five minutes. Both printed and
electronic copies are requested for the record. In addition, any
interested person may file written comments with the committee by
forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation
of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://www.ninr.nih.gov/aboutninr/nacnr, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
Dated: September 25, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21433 Filed 9-28-23; 8:45 am]
BILLING CODE 4140-01-P
